SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,315,200 | +17.4% | 179,929 | +0.1% | 1.41% | +47.6% |
| Q3 2022 | $19,868,000 | +26.8% | 179,734 | -14.0% | 0.96% | +22.1% |
| Q2 2022 | $15,671,000 | -0.1% | 209,060 | +4.1% | 0.78% | +21.2% |
| Q1 2022 | $15,686,000 | -42.6% | 200,800 | -33.8% | 0.64% | -3.2% |
| Q4 2021 | $27,324,000 | -0.7% | 303,430 | +2.0% | 0.67% | +20.9% |
| Q3 2021 | $27,508,000 | +20.9% | 297,444 | +1.6% | 0.55% | +43.9% |
| Q2 2021 | $22,758,000 | +470.9% | 292,744 | +447.4% | 0.38% | +790.7% |
| Q1 2021 | $3,986,000 | -90.4% | 53,478 | -78.0% | 0.04% | -89.1% |
| Q4 2020 | $41,429,000 | – | 243,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |